Clinical Approach to Memory Impairment

Comprehensive Practical Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of memory impairment

Memory impairment is one of the most common cognitive complaints encountered in clinical practice. Approximately 12-18% of adults over age 60 experience subjective memory complaints, and memory-related concerns account for a substantial proportion of neurology referrals. Mild cognitive impairment affects approximately 15-20% of individuals over age 65, with 10-15% progressing to dementia annually. Dementia itself affects over 55 million people worldwide, with Alzheimer’s disease accounting for 60-70% of cases. Importantly, up to 20% of patients presenting with memory concerns have reversible or treatable causes.

Definition

Memory impairment refers to a reduction in the ability to encode, store, or retrieve information. Memory is not a unitary function but comprises multiple distinct systems subserved by different brain regions. Clinically significant memory impairment represents a decline from a previous level of functioning that may or may not interfere with daily activities, depending on severity.

Classification by Onset and Duration

Category	Onset/Duration	Common Causes	Clinical Significance
Acute	Minutes to hours	Transient global amnesia, stroke, seizures, head trauma, intoxication	Often reversible; requires urgent evaluation to exclude vascular or epileptic etiology
Subacute	Days to weeks	Autoimmune encephalitis, Wernicke encephalopathy, infections, rapidly progressive dementias	High urgency; many causes are treatable if identified early
Chronic	Months to years	Alzheimer’s disease, vascular dementia, frontotemporal dementia, Lewy body dementia	Progressive in most cases; focus on reversible contributors and supportive care

Classification by Memory Type Affected

Episodic Memory

Memory for personal events and experiences with temporal and spatial context. Impairment manifests as forgetting recent conversations, appointments, or where items were placed. Most commonly affected in Alzheimer’s disease and hippocampal pathology.

Semantic Memory

Memory for facts, concepts, and general knowledge independent of personal experience. Impairment presents as word-finding difficulties, loss of object knowledge, or inability to recognize familiar faces. Characteristic of semantic variant primary progressive aphasia.

Working Memory

Temporary storage and manipulation of information for complex tasks. Impairment manifests as difficulty following conversations, losing track of tasks, or inability to perform mental calculations. Often affected in frontal lobe dysfunction and normal aging.

Procedural Memory

Memory for skills and motor sequences, typically implicit and automatic. Usually preserved in Alzheimer’s disease but impaired in basal ganglia disorders such as Parkinson’s disease and Huntington’s disease.

Classification by Pattern of Progression

Pattern	Description	Suggests
Gradually progressive	Slow, insidious decline over months to years	Neurodegenerative disease (Alzheimer’s disease, frontotemporal dementia)
Stepwise progression	Periods of stability punctuated by sudden declines	Vascular dementia, recurrent strokes
Rapidly progressive	Significant decline over weeks to months	Prion disease, autoimmune encephalitis, malignancy, infections
Fluctuating	Marked day-to-day or hour-to-hour variability	Lewy body dementia, delirium, metabolic encephalopathy
Static	Stable deficit without progression	Post-stroke, post-anoxic injury, post-traumatic

Classification by Temporal Gradient

Type	Definition	Clinical Features	Associated Conditions
Anterograde amnesia	Inability to form new memories after onset of impairment	Patient cannot recall recent events; asks repetitive questions; forgets appointments	Hippocampal lesions, Alzheimer’s disease, Korsakoff syndrome, transient global amnesia
Retrograde amnesia	Loss of memories formed before onset of impairment	Cannot recall past events; often follows temporal gradient (remote memories preserved longer)	Severe head trauma, encephalitis, Korsakoff syndrome, psychogenic amnesia

Key Concept: The Reversible Causes

Always consider potentially reversible causes of memory impairment, remembered by the mnemonic “DEMENTIA”:

Drugs and toxins (anticholinergics, sedatives, alcohol)
Emotional disorders (depression, anxiety)
Metabolic disorders (thyroid dysfunction, B12 deficiency, electrolyte abnormalities)
Eyes and ears (sensory impairment mimicking cognitive decline)
Normal pressure hydrocephalus
Tumors and other structural lesions
Infections (neurosyphilis, HIV, chronic meningitis)
Anemia and anoxia

These potentially treatable causes account for up to 20% of dementia presentations and should be systematically excluded.

2. Pathophysiology and Mechanisms

Understanding the underlying mechanisms of memory impairment

Memory is not a single entity but comprises multiple interrelated systems supported by distinct neural circuits. Understanding these systems helps localize pathology and predict patterns of impairment. Memory formation involves three fundamental processes: encoding (acquiring new information), consolidation (stabilizing memories over time), and retrieval (accessing stored information). Disruption at any stage produces clinically apparent memory impairment, though the pattern differs depending on the affected process and underlying neural substrate.

Memory Systems and Neural Substrates

Memory System	Key Brain Structures	Function	Clinical Correlation
Episodic Memory	Hippocampus, entorhinal cortex, parahippocampal gyrus, fornix	Encoding and retrieval of autobiographical events with spatiotemporal context	Early impairment in Alzheimer’s disease; affected in limbic encephalitis
Semantic Memory	Anterior temporal lobes (especially left), inferior temporal cortex	Storage of factual knowledge, concepts, and word meanings	Semantic dementia; late-stage Alzheimer’s disease
Working Memory	Dorsolateral prefrontal cortex, posterior parietal cortex	Temporary maintenance and manipulation of information	Frontal lobe lesions; executive dysfunction syndromes
Procedural Memory	Basal ganglia (striatum), cerebellum, supplementary motor area	Acquisition of motor skills and habits	Parkinson’s disease; Huntington’s disease; cerebellar disorders

The Papez Circuit: Core Memory Network

The Papez circuit is the classical neural pathway underlying episodic memory formation. Damage to any component produces anterograde amnesia:

Structure	Connection	Function	Lesion Effect
Hippocampus	Receives input from entorhinal cortex; projects to mammillary bodies via fornix	Encoding and early consolidation of declarative memories	Profound anterograde amnesia (bilateral lesions); transient global amnesia
Fornix	Major output pathway from hippocampus to mammillary bodies and septal nuclei	Transmission of hippocampal output to diencephalic structures	Memory impairment (surgical section, tumors, demyelination)
Mammillary Bodies	Receives fornix input; projects to anterior thalamus via mammillothalamic tract	Relay station in memory circuit	Korsakoff syndrome (thiamine deficiency); Wernicke encephalopathy
Anterior Thalamus	Receives mammillothalamic tract; projects to cingulate cortex	Integration of memory with emotional and attentional processes	Thalamic infarcts; thalamic tumors causing amnesia
Cingulate Cortex	Receives thalamic input; projects back to hippocampal formation	Attention, emotional processing, and memory retrieval	Impaired retrieval; behavioral variant frontotemporal dementia

Neurotransmitter Systems in Memory

Cholinergic System

Source: Nucleus basalis of Meynert, septal nuclei

Role: Attention, encoding of new memories, cortical activation

Clinical relevance: Degeneration in Alzheimer’s disease; basis for cholinesterase inhibitor therapy; anticholinergic medications impair memory

Glutamatergic System

Source: Hippocampal pyramidal neurons, cortical neurons

Role: Long-term potentiation (synaptic strengthening), memory consolidation via NMDA receptors

Clinical relevance: Target of memantine in moderate-severe Alzheimer’s disease; excitotoxicity in ischemia and neurodegeneration

Noradrenergic System

Source: Locus coeruleus

Role: Arousal, attention, emotional memory enhancement

Clinical relevance: Early degeneration in Alzheimer’s disease; stress hormones enhance emotional memory consolidation

How Conditions Cause Memory Impairment

Condition	Mechanism	Pattern of Memory Impairment
Alzheimer’s disease	Amyloid-beta plaques and tau neurofibrillary tangles cause synaptic dysfunction and neuronal loss, beginning in entorhinal cortex and hippocampus; cholinergic deficit from basal forebrain degeneration	Early episodic memory impairment (anterograde > retrograde); semantic memory affected later; procedural memory relatively preserved
Vascular dementia	Ischemic damage to strategic memory structures (hippocampus, thalamus, fornix) or cumulative white matter disease disrupting frontal-subcortical circuits	Variable pattern; often prominent executive dysfunction with retrieval deficits; may show stepwise progression
Lewy body dementia	Alpha-synuclein aggregates in cortical neurons; prominent cholinergic deficit; dopaminergic dysfunction	Fluctuating attention and cognition; memory impairment often less prominent than visuospatial and executive dysfunction
Frontotemporal dementia	Tau or TDP-43 protein aggregation causing frontal and temporal lobe atrophy; neuronal loss in anterior temporal regions	Behavioral variant: executive dysfunction predominates, episodic memory often preserved early; Semantic variant: profound semantic memory loss
Wernicke-Korsakoff syndrome	Thiamine deficiency causes hemorrhagic necrosis of mammillary bodies, medial thalamus, and periaqueductal gray	Profound anterograde amnesia with relative preservation of other cognitive domains; confabulation; temporally graded retrograde amnesia
Autoimmune encephalitis (anti-LGI1, anti-NMDAR)	Antibodies against neuronal surface antigens cause synaptic dysfunction in limbic structures; inflammation and neuronal injury	Rapid-onset anterograde amnesia; often with seizures, psychiatric symptoms, and movement disorders
Transient global amnesia	Uncertain mechanism; possibly venous congestion, spreading cortical depression, or transient hippocampal ischemia	Acute-onset dense anterograde amnesia with variable retrograde amnesia; complete recovery within 24 hours; personal identity preserved
Depression (pseudodementia)	Reduced hippocampal neurogenesis; prefrontal dysfunction; reduced motivation and attention; elevated cortisol	Retrieval deficits rather than encoding problems; often improves with cueing; subjective complaints may exceed objective impairment

Often Overlooked Mechanism: Retrieval Versus Encoding Deficits

Not all memory impairment reflects true amnesia. Patients with frontal-subcortical dysfunction (vascular disease, depression, Parkinson’s disease) often have retrieval deficits rather than encoding failures. These patients perform poorly on free recall but improve dramatically with cues or recognition testing—the memory trace was formed but cannot be accessed spontaneously. In contrast, patients with hippocampal pathology (Alzheimer’s disease, limbic encephalitis) have encoding deficits—cues do not help because the memory was never properly formed. This distinction has important diagnostic and therapeutic implications.

Cellular and Molecular Mechanisms of Memory Formation

Process	Mechanism	Time Scale	Clinical Relevance
Long-term potentiation	NMDA receptor activation leads to calcium influx, AMPA receptor insertion, and synaptic strengthening	Minutes to hours	Target of memantine; disrupted by hypoxia and excitotoxicity
Synaptic consolidation	Protein synthesis-dependent structural changes at synapses; CREB activation	Hours to days	Requires adequate sleep; disrupted by protein synthesis inhibitors
Systems consolidation	Gradual transfer of memories from hippocampus to neocortex through repeated reactivation, particularly during sleep	Weeks to years	Explains temporal gradient of retrograde amnesia (older memories more resistant)
Neurogenesis	New neuron formation in dentate gyrus; enhanced by exercise, environmental enrichment; suppressed by stress and depression	Ongoing process	May contribute to antidepressant effects on cognition; reduced in aging

3. History Taking

A comprehensive approach to eliciting the memory impairment history

Red Flags — Require Urgent Evaluation

Rapid progression (weeks to months) — Prion disease, autoimmune encephalitis, malignancy
New-onset seizures — Autoimmune encephalitis, tumor, stroke
Fever or systemic illness — Infectious encephalitis, sepsis-related delirium
Sudden onset — Stroke, transient global amnesia, seizure
Prominent psychiatric features — Autoimmune encephalitis (especially anti-NMDA receptor)

New headache or papilledema — Mass lesion, normal pressure hydrocephalus, venous thrombosis
Focal neurological signs — Stroke, tumor, abscess
Gait disturbance and incontinence — Normal pressure hydrocephalus (potentially reversible)
Movement disorder (myoclonus, chorea) — Prion disease, autoimmune encephalitis
Age under 65 with progressive symptoms — Early-onset dementia requiring specialized evaluation

Systematic History: The “MEMORY” Approach

Use the mnemonic “MEMORY” to ensure comprehensive history taking:

M — Mode of onset and course: When did symptoms begin? Was onset sudden, subacute, or gradual? Is progression steady, stepwise, or fluctuating?
E — Examples and domains: What specific problems occur? (Forgetting conversations, getting lost, word-finding, misplacing items) Which cognitive domains are affected?
M — Medications and substances: Review all medications (especially anticholinergics, sedatives, opioids). Assess alcohol use, recreational drugs, over-the-counter supplements.
O — Other symptoms: Mood changes, hallucinations, sleep disturbance, gait problems, incontinence, personality changes, motor symptoms?
R — Risk factors and past history: Vascular risk factors, head trauma, family history of dementia, prior psychiatric illness, thyroid disease?
Y — Your daily life impact: How do symptoms affect work, driving, finances, medication management, cooking, and other instrumental activities of daily living?

Critical: Obtain Collateral History

Memory-impaired patients may have limited insight or be unable to provide accurate details. Always interview a family member, caregiver, or close friend separately. Discrepancies between patient and informant accounts are diagnostically valuable—patients with Alzheimer’s disease often minimize deficits, while those with depression may exaggerate them.

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Alzheimer’s disease	Gradual onset, progressive course, early episodic memory loss, word-finding difficulty	“Do they ask the same questions repeatedly? Forget recent conversations but remember events from years ago?”
Vascular dementia	Stepwise progression, vascular risk factors, may follow stroke	“Has there been a sudden worsening, or periods where they seemed stable then declined? Any history of stroke or TIA?”
Lewy body dementia	Fluctuations, visual hallucinations, parkinsonism, REM sleep behavior disorder	“Does their alertness vary dramatically hour to hour or day to day? Do they see people or animals that aren’t there? Do they act out dreams?”
Frontotemporal dementia	Personality change, disinhibition, apathy, language problems, age typically under 65	“Has their personality changed? Are they doing things out of character—inappropriate comments, loss of empathy, new obsessions?”
Normal pressure hydrocephalus	Triad: gait disturbance, urinary incontinence, dementia (gait usually first)	“Did walking problems start before or around the same time as memory problems? Any new urinary urgency or incontinence?”
Depression (pseudodementia)	Mood symptoms, loss of interest, complaints exceed objective findings, may improve with cueing	“Have they lost interest in activities they used to enjoy? Do they seem sad, hopeless, or anxious? Is the memory problem worse when mood is low?”
Autoimmune encephalitis	Subacute onset, seizures, psychiatric symptoms, movement disorders	“Did this come on over days to weeks? Any new seizures, confusion episodes, or unusual movements? Any recent viral illness or tumor diagnosis?”
Creutzfeldt-Jakob disease	Rapid progression, myoclonus, ataxia, visual symptoms	“How quickly has this progressed? Any jerking movements, difficulty walking, or vision changes? Any prior surgery or growth hormone treatment?”
Wernicke-Korsakoff syndrome	Alcohol history, confabulation, relatively preserved other cognition	“How much alcohol do they drink? Do they make up stories or fill in gaps without realizing? Any history of malnutrition or bariatric surgery?”
Transient global amnesia	Sudden onset, repetitive questioning, resolves within 24 hours	“Did this come on suddenly? Were they asking the same questions over and over? Has it completely resolved now?”

Functional Assessment: Activities of Daily Living

Instrumental Activities of Daily Living (IADLs)

Affected earlier in dementia:

Finances: Paying bills, managing accounts
Medications: Taking correct doses at correct times
Transportation: Driving safely, using public transport
Shopping: Making appropriate purchases
Cooking: Preparing meals, following recipes
Housework: Maintaining the home
Communication: Using telephone, technology

Basic Activities of Daily Living (BADLs)

Affected later in dementia:

Bathing: Personal hygiene
Dressing: Selecting and putting on clothes
Toileting: Using the bathroom independently
Transferring: Getting in/out of bed or chair
Continence: Bowel and bladder control
Feeding: Eating independently

Medication and Substance History

Medications That Impair Memory

Anticholinergics — Antihistamines (diphenhydramine), tricyclic antidepressants, bladder antimuscarinics (oxybutynin), antipsychotics
Benzodiazepines — Dose-dependent impairment; particularly problematic in elderly
Opioids — Sedation, impaired attention and encoding
Antiepileptics — Topiramate, phenobarbital, phenytoin
Corticosteroids — Hippocampal effects with chronic use
Beta-blockers (lipophilic) — Propranolol, metoprolol
H2 blockers — Cimetidine, ranitidine (especially in elderly)

Substance Use Assessment

Alcohol: Quantity, frequency, duration, history of withdrawal, blackouts, nutritional status (Wernicke-Korsakoff risk)
Cannabis: Heavy use associated with memory impairment, particularly in younger users
Recreational drugs: MDMA, methamphetamine, cocaine—neurotoxic effects
Inhalants: Toluene and other solvents cause white matter damage
Over-the-counter supplements: Many contain anticholinergics or sedatives

Family History and Risk Factors

Risk Factor	Relevance	Key Questions
Family history of dementia	Increases risk 2-4 fold; earlier onset in affected relative suggests genetic component	“Did any first-degree relatives develop dementia? At what age? What type?”
Cardiovascular risk factors	Hypertension, diabetes, hyperlipidemia, smoking, obesity increase vascular and Alzheimer’s dementia risk	“Do they have high blood pressure, diabetes, high cholesterol? Do they smoke?”
Head trauma	Traumatic brain injury increases dementia risk; repetitive trauma associated with chronic traumatic encephalopathy	“Any history of head injury with loss of consciousness? Contact sports? Military service with blast exposure?”
Education and occupation	Higher education/cognitive reserve may delay symptom onset but not pathology	“What is their highest level of education? What was their occupation?”
Sleep disorders	Obstructive sleep apnea associated with cognitive decline; REM sleep behavior disorder precedes Lewy body dementia	“Do they snore heavily or stop breathing at night? Do they act out dreams?”
Psychiatric history	Depression is both risk factor and differential diagnosis; late-life psychiatric onset may herald neurodegeneration	“Any history of depression, anxiety, or psychiatric illness? When did it first occur?”

4. Physical Examination

A systematic approach for patients presenting with memory impairment

Systematic Framework: The examination of a patient with memory impairment combines a thorough cognitive assessment with a complete neurological examination and general medical examination to identify both the pattern of cognitive deficits and potential underlying causes.

General Inspection

Appearance and hygiene: Neglect of personal care suggests functional impairment or depression; disheveled appearance in previously meticulous person is significant
Nutritional status: Weight loss may indicate depression, malignancy, or inability to prepare meals; cachexia raises concern for serious underlying illness
Level of alertness: Fluctuating consciousness suggests delirium or Lewy body dementia; obtundation requires urgent evaluation
Behavior: Disinhibition, apathy, or inappropriate affect may indicate frontotemporal dementia; agitation or fearfulness may suggest delirium
Speech: Listen for word-finding pauses, paraphasic errors, or reduced output before formal testing

Vital Signs

Vital Sign	What to Look For	Clinical Significance
Temperature	Fever or hypothermia	Fever: infection, encephalitis, autoimmune process. Hypothermia: hypothyroidism, sepsis in elderly
Blood Pressure	Hypertension; significant orthostatic drop	Chronic hypertension: vascular dementia risk. Orthostatic hypotension: Lewy body dementia, autonomic failure
Heart Rate	Bradycardia, tachycardia, irregularity	Bradycardia: hypothyroidism. Atrial fibrillation: embolic stroke risk. Tachycardia: infection, thyrotoxicosis
Respiratory Rate	Tachypnea, abnormal patterns	May indicate hypoxia, metabolic acidosis, or respiratory infection contributing to encephalopathy
Oxygen Saturation	Hypoxemia	Chronic hypoxia from pulmonary or cardiac disease contributes to cognitive impairment

Cognitive Examination

A structured cognitive assessment is essential. The Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA) provide standardized screening, but bedside assessment of individual domains adds diagnostic value:

Domain	How to Test	Abnormal Finding Suggests
Orientation	Date, day, month, year, season; location (building, city, state)	Disorientation to time before place; seen in delirium and moderate-severe dementia
Attention	Digit span (forward and backward), serial 7s, spelling WORLD backward, months backward	Poor attention: delirium, depression, frontal dysfunction. Must be intact for valid memory testing
Registration	Repeat three words immediately	Failure suggests severe attentional impairment or hearing loss rather than memory disorder
Delayed Recall	Recall three words after 5 minutes; note if cues help	Impaired free recall with improvement on cueing: retrieval deficit (frontal, depression). No improvement with cues: encoding deficit (hippocampal, Alzheimer’s)
Language	Naming (pen, watch, parts), repetition, comprehension, reading, writing; verbal fluency (animals in 1 minute)	Anomia: Alzheimer’s, semantic dementia. Poor fluency: frontal dysfunction. Paraphasias: primary progressive aphasia
Visuospatial	Clock drawing, intersecting pentagons, cube copy	Early impairment in Lewy body dementia and posterior cortical atrophy; often preserved early in Alzheimer’s
Executive Function	Luria sequences, go-no-go, Trails B, abstraction (similarities), judgment	Early impairment in frontotemporal dementia, vascular dementia, Lewy body dementia

Practical Tip: The Clock Drawing Test

Ask the patient to draw a clock face, put in all the numbers, and set the hands to “ten past eleven” (11:10). This simple test assesses multiple domains simultaneously: visuospatial function, executive planning, semantic knowledge, and attention. Specific error patterns have diagnostic value—number crowding on one side suggests hemispatial neglect, while conceptual errors (digital time representation, misplaced numbers) suggest more severe cognitive impairment.

Neurological Examination

Cranial Nerves

Finding	How to Detect	Clinical Significance
Visual field defect	Confrontation testing	Homonymous hemianopia: stroke, tumor. Suggests posterior circulation or posterior cortical pathology
Pupillary abnormalities	Size, symmetry, light response	Argyll Robertson pupils: neurosyphilis. Anisocoria with ptosis: Horner syndrome (carotid dissection)
Eye movement abnormalities	Smooth pursuit, saccades, gaze palsy	Vertical gaze palsy: progressive supranuclear palsy. Nystagmus: Wernicke encephalopathy, cerebellar disease
Facial asymmetry	Observe at rest and with movement	Upper motor neuron pattern: stroke. Lower motor neuron: cranial neuropathy
Dysarthria	Listen during conversation; test “pa-ta-ka”	Scanning speech: cerebellar. Hypophonia: Parkinson’s disease. Spastic: pseudobulbar palsy

Motor Examination

Finding	Description	Associated Conditions
Rigidity	Increased tone throughout range; cogwheel (ratchety) or lead-pipe quality	Parkinson’s disease, Lewy body dementia, vascular parkinsonism, progressive supranuclear palsy
Bradykinesia	Slowness and decrement of repetitive movements (finger tapping, hand opening/closing)	Parkinson’s disease, Lewy body dementia, drug-induced parkinsonism
Tremor	Resting tremor (pill-rolling), postural tremor, action tremor	Resting: Parkinson’s disease. Postural: essential tremor. Action: cerebellar disease
Myoclonus	Sudden, brief, shock-like jerks; may be spontaneous or stimulus-induced	Creutzfeldt-Jakob disease, advanced Alzheimer’s, metabolic encephalopathy, Lewy body dementia
Chorea	Irregular, flowing, dance-like involuntary movements	Huntington’s disease, vascular chorea, autoimmune encephalitis
Weakness pattern	Hemiparesis, paraparesis, or focal weakness	Stroke (hemiparesis), spinal cord disease, motor neuron disease (if combined with dementia: ALS-FTD spectrum)

Gait Assessment

Gait Pattern	Description	Associated Conditions
Magnetic gait (apraxic)	Wide-based, short shuffling steps, feet appear “stuck” to floor, difficulty initiating, turns require multiple steps	Normal pressure hydrocephalus, vascular dementia (Binswanger’s disease)
Parkinsonian gait	Narrow-based shuffling, reduced arm swing, stooped posture, festination, difficulty turning	Parkinson’s disease, Lewy body dementia, vascular parkinsonism
Ataxic gait	Wide-based, unsteady, irregular step length, difficulty with tandem walking	Cerebellar disease, Wernicke encephalopathy, spinocerebellar ataxias
Hemiparetic gait	Circumduction of affected leg, arm held in flexion	Stroke, tumor, or other focal lesion
Frontal gait disorder	Difficulty initiating movement, wide-based, shuffling; may have “ignition failure”	Frontal lobe pathology, normal pressure hydrocephalus, vascular dementia

Primitive Reflexes (Frontal Release Signs)

Grasp reflex: Stroke palm; pathological if patient involuntarily grips examiner’s fingers — suggests frontal lobe dysfunction
Palmomental reflex: Scratch thenar eminence; ipsilateral chin muscle contraction — frontal lobe disease (low specificity)
Snout reflex: Tap upper lip; pursing response — bilateral frontal dysfunction
Glabellar tap: Repeated tapping between eyebrows; failure to habituate (continued blinking) — Parkinson’s disease, frontal lobe disease

General Medical Examination

Cardiovascular

Carotid bruits (vascular disease)
Irregular pulse (atrial fibrillation)
Cardiac murmurs (embolic source)
Peripheral edema (heart failure)
Orthostatic hypotension (Lewy body, autonomic failure)

Thyroid and Neck

Goiter (thyroid disease)
Thyroid nodules
Signs of hypothyroidism (dry skin, slow relaxing reflexes, periorbital edema)
Signs of hyperthyroidism (tremor, tachycardia, lid lag)

Skin

Jaundice (hepatic encephalopathy)
Pallor (anemia)
Hyperpigmentation (Addison’s disease)
Stigmata of liver disease (alcohol-related)
Rashes (vasculitis, systemic lupus erythematosus)

Fundoscopy

Papilledema (raised intracranial pressure)
Hypertensive retinopathy (chronic hypertension)
Diabetic retinopathy (microvascular disease)
Pallor of optic disc (optic atrophy)

Expected Findings by Etiology

Condition	Cognitive Pattern	Neurological Findings	Other Findings
Alzheimer’s disease	Impaired delayed recall (no benefit from cues), anomia, visuospatial impairment later	Often normal early; may develop myoclonus late	Usually normal general examination
Vascular dementia	Executive dysfunction, slowed processing, retrieval deficits	Focal signs (hemiparesis, hyperreflexia), pseudobulbar affect, gait disorder	Evidence of vascular disease (bruits, absent pulses)
Lewy body dementia	Fluctuating attention, visuospatial impairment, relatively preserved memory early	Parkinsonism (rigidity, bradykinesia), REM sleep behavior disorder history	Orthostatic hypotension, visual hallucinations, neuroleptic sensitivity
Frontotemporal dementia	Executive dysfunction, apathy or disinhibition, relatively preserved memory; language variant: aphasia	Primitive reflexes, may have motor neuron signs (ALS-FTD)	Behavioral changes, loss of empathy, dietary changes
Normal pressure hydrocephalus	Subcortical pattern: slowed processing, attention deficits, retrieval impairment	Magnetic/apraxic gait (most prominent finding), urinary urgency/incontinence	Triad: gait disturbance (earliest), urinary symptoms, dementia
Creutzfeldt-Jakob disease	Rapid global cognitive decline, cortical blindness in variant forms	Myoclonus, ataxia, pyramidal and extrapyramidal signs	Rapid progression; akinetic mutism late
Wernicke-Korsakoff	Profound anterograde amnesia, confabulation, relative preservation of other domains	Ophthalmoplegia, nystagmus, ataxia (Wernicke triad—often incomplete)	Signs of malnutrition, stigmata of alcohol use

Important Teaching Point

A normal neurological examination is common in early dementia! Patients with early Alzheimer’s disease, depression-related cognitive impairment, and many other causes of memory complaints often have completely normal neurological examinations. The absence of focal signs does not exclude significant pathology. Conversely, the presence of specific findings (parkinsonism, gait disorder, focal deficits) significantly narrows the differential diagnosis and should prompt targeted investigation.

5. Differential Diagnosis

Systematic approach organized by probability, acuity, and clinical features

Acute Memory Impairment (Onset: Minutes to Hours)

Probability	Condition	Key Features	Red Flags
COMMON	Transient global amnesia	Sudden onset dense anterograde amnesia; repetitive questioning; resolves within 24 hours; personal identity preserved	Recurrence (consider epilepsy); focal signs (consider stroke)
COMMON	Delirium (acute confusional state)	Fluctuating attention and awareness; acute onset; identifiable precipitant (infection, medications, metabolic)	Fever; focal signs; no identifiable cause
LESS COMMON	Transient epileptic amnesia	Brief episodes (usually less than 1 hour); often on waking; may have subtle motor features; recurrent	Prolonged episodes; other seizure types
LESS COMMON	Acute stroke (strategic infarct)	Sudden onset; infarct in hippocampus, thalamus, or posterior cerebral artery territory	Focal neurological signs; vascular risk factors; atrial fibrillation
UNCOMMON BUT SERIOUS	Subarachnoid hemorrhage	Thunderclap headache; may present with confusion and amnesia for event	Severe headache; neck stiffness; decreased consciousness
UNCOMMON BUT SERIOUS	Hypoglycemia	Confusion, amnesia; diabetic patient on insulin or sulfonylureas	Altered consciousness; seizures; focal signs (rare)
UNCOMMON BUT SERIOUS	Wernicke encephalopathy	Acute/subacute confusion; ophthalmoplegia; ataxia; alcohol or malnutrition history	Complete triad present in only 10-15%; requires immediate thiamine

Subacute Memory Impairment (Onset: Days to Weeks)

High-Urgency Category

Subacute onset memory impairment requires urgent investigation. Many causes in this category are treatable if identified early but cause permanent damage if delayed. Always consider autoimmune encephalitis, infections, and rapidly progressive dementias.

Probability	Condition	Key Features	Urgent Investigation
LESS COMMON BUT TREATABLE	Autoimmune encephalitis (anti-LGI1, anti-CASPR2)	Subacute amnesia; faciobrachial dystonic seizures; hyponatremia; psychiatric symptoms	MRI brain; CSF analysis; serum and CSF autoantibody panel
LESS COMMON BUT TREATABLE	Anti-NMDA receptor encephalitis	Young women; psychiatric presentation; seizures; movement disorders; autonomic instability; may have ovarian teratoma	CSF autoantibodies; MRI; pelvic ultrasound/CT for teratoma
LESS COMMON BUT TREATABLE	Herpes simplex encephalitis	Fever; headache; behavioral change; seizures; temporal lobe predilection	MRI brain; CSF HSV PCR—treat empirically while awaiting results
LESS COMMON BUT TREATABLE	Wernicke-Korsakoff syndrome	Alcohol history; malnutrition; bariatric surgery; classic triad often incomplete	Treat with IV thiamine before investigations; MRI may show mammillary body changes
UNCOMMON BUT SERIOUS	Creutzfeldt-Jakob disease	Rapid cognitive decline over weeks to months; myoclonus; ataxia; visual symptoms	MRI (cortical ribboning, DWI); CSF 14-3-3, RT-QuIC; EEG
UNCOMMON BUT SERIOUS	CNS lymphoma	Progressive cognitive decline; may have focal signs; immunocompromised patients at higher risk	MRI with contrast; CSF cytology; consider biopsy
UNCOMMON BUT SERIOUS	Paraneoplastic limbic encephalitis	Subacute amnesia; psychiatric symptoms; may precede cancer diagnosis by months	Paraneoplastic antibody panel; CT chest/abdomen/pelvis; PET scan

Chronic Memory Impairment (Onset: Months to Years)

Step-by-Step Approach to Chronic Memory Impairment:

Step 1: Exclude delirium — Is this truly chronic, or acute-on-chronic?
Step 2: Screen for reversible causes — Depression, medications, metabolic disorders, B12/folate, thyroid
Step 3: Characterize the cognitive profile — Which domains are affected? Pattern suggests etiology
Step 4: Look for associated features — Parkinsonism, gait disorder, behavioral change, hallucinations
Step 5: Neuroimaging — MRI to assess atrophy pattern and exclude structural lesions

Probability	Condition	Approximate Frequency	Key Distinguishing Features
COMMON	Alzheimer’s disease	60-70% of dementia cases	Gradual onset; early episodic memory impairment; word-finding difficulty; visuospatial dysfunction later; hippocampal atrophy on MRI
COMMON	Vascular dementia	15-20% of dementia cases	Stepwise progression; vascular risk factors; executive dysfunction; focal signs; white matter changes on MRI
COMMON	Mixed dementia (Alzheimer’s + vascular)	10-20% of dementia cases	Features of both; very common in elderly; vascular pathology lowers threshold for Alzheimer’s symptoms
LESS COMMON	Lewy body dementia	5-15% of dementia cases	Fluctuating cognition; visual hallucinations; parkinsonism; REM sleep behavior disorder; neuroleptic sensitivity
LESS COMMON	Frontotemporal dementia (behavioral variant)	5-10% of dementia cases	Personality change; disinhibition or apathy; loss of empathy; dietary changes; relatively preserved memory early; frontal atrophy
LESS COMMON	Parkinson’s disease dementia	3-5% of dementia cases	Parkinsonism precedes dementia by at least 1 year (distinguishes from Lewy body dementia); executive dysfunction; visual hallucinations
LESS COMMON BUT TREATABLE	Depression (pseudodementia)	Variable; common contributor	Mood symptoms; subjective complaints may exceed objective findings; improves with cueing; “I don’t know” responses; treatment-responsive
LESS COMMON BUT TREATABLE	Normal pressure hydrocephalus	2-5% of dementia cases	Triad: gait disturbance (first), urinary incontinence, dementia; magnetic gait; ventricular enlargement out of proportion to atrophy
UNCOMMON	Primary progressive aphasia	Less than 5% of dementia cases	Language impairment predominates; three variants: semantic, non-fluent, logopenic; memory relatively preserved early
UNCOMMON	Posterior cortical atrophy	Less than 5% of dementia cases	Visual processing deficits (reading, recognizing objects, navigating); relatively preserved memory; posterior atrophy; often Alzheimer’s pathology
UNCOMMON	Huntington’s disease	Rare	Chorea; family history (autosomal dominant); psychiatric symptoms; subcortical dementia pattern; caudate atrophy

Anatomical Approach to Memory Impairment

Medial Temporal / Hippocampal

Alzheimer’s disease

Limbic encephalitis

Herpes simplex encephalitis

Posterior cerebral artery stroke

Transient global amnesia

Hypoxic-ischemic injury

Diencephalic (Thalamus / Mammillary Bodies)

Wernicke-Korsakoff syndrome

Thalamic stroke

Third ventricle tumors

Thalamic dementia

Artery of Percheron infarct

Frontal / Subcortical

Frontotemporal dementia

Vascular dementia (subcortical)

Normal pressure hydrocephalus

Progressive supranuclear palsy

Huntington’s disease

Depression

Diffuse / Multifocal

Lewy body dementia

Creutzfeldt-Jakob disease

Metabolic encephalopathies

Autoimmune encephalitis

CNS vasculitis

Multiple sclerosis

Potentially Reversible Causes of Memory Impairment

Category	Specific Causes	Key Investigation	Expected Improvement
Metabolic	Hypothyroidism, hyperthyroidism, hyponatremia, hypercalcemia, hepatic encephalopathy, uremia	TSH, electrolytes, calcium, liver function, renal function	Full reversal if treated early; partial if chronic
Nutritional	Vitamin B12 deficiency, folate deficiency, thiamine deficiency (Wernicke-Korsakoff)	B12, folate, methylmalonic acid; thiamine level (unreliable—treat empirically)	B12: variable, may be partial; Thiamine: prevent Korsakoff but may not reverse
Infectious	Neurosyphilis, HIV-associated neurocognitive disorder, chronic meningitis	Syphilis serology, HIV, CSF analysis	Neurosyphilis: may stabilize or improve; HIV: HAART can improve cognition
Structural	Normal pressure hydrocephalus, subdural hematoma, brain tumor	MRI brain with contrast	NPH: 60-80% improve with shunting; SDH/tumor: depends on extent
Psychiatric	Depression, anxiety, severe stress	Clinical assessment; depression screening (PHQ-9, GDS)	Often significant improvement with treatment
Medication-induced	Anticholinergics, benzodiazepines, opioids, antiepileptics	Medication review; Anticholinergic Burden Score	Often significant improvement after discontinuation
Autoimmune	Autoimmune encephalitis, CNS vasculitis, neurosarcoidosis	Autoantibody panels, CSF analysis, angiography, biopsy	Variable; early treatment improves outcomes
Sleep disorders	Obstructive sleep apnea	Polysomnography	Cognitive improvement with CPAP treatment

Drug-Induced Memory Impairment

Drug or Drug Class	Mechanism	Characteristics	Time to Resolution After Stopping
Anticholinergics (diphenhydramine, oxybutynin, tricyclics, antipsychotics)	Block muscarinic acetylcholine receptors; impair hippocampal function	Dose-dependent; elderly highly susceptible; cumulative burden matters	Days to weeks; some evidence of persistent effects with long-term use
Benzodiazepines (diazepam, lorazepam, alprazolam)	GABA-A receptor enhancement; impair encoding and consolidation	Anterograde amnesia; long-acting agents accumulate in elderly	Days to weeks depending on half-life; may be prolonged in elderly
Z-drugs (zolpidem, zopiclone)	GABA-A modulation similar to benzodiazepines	Complex sleep behaviors with amnesia; next-day cognitive effects	Days; usually faster than benzodiazepines
Opioids (morphine, oxycodone, fentanyl)	Sedation; impaired attention and encoding; possible direct hippocampal effects	Dose-dependent sedation and cognitive slowing	Days to weeks depending on duration of use
Antiepileptics (topiramate, phenobarbital, phenytoin)	Variable: GABA enhancement, glutamate inhibition, sodium channel effects	Topiramate: word-finding difficulty; Phenobarbital: sedation; Phenytoin: chronic toxicity	Weeks to months; phenytoin effects may persist
Corticosteroids	Hippocampal glucocorticoid receptor effects; neuronal atrophy with chronic use	Dose-dependent; “steroid psychosis” in acute; memory impairment with chronic use	Variable; chronic effects may be partially irreversible
Beta-blockers (lipophilic) (propranolol, metoprolol)	CNS penetration; mechanism unclear but may affect noradrenergic memory modulation	Fatigue, depression, cognitive slowing; elderly more susceptible	Days to weeks
Histamine H2 blockers (cimetidine, famotidine)	CNS histamine receptor effects; possible anticholinergic activity (cimetidine)	Confusion especially in elderly or renal impairment	Days

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Rapid progression (weeks to months)	Prion disease, autoimmune encephalitis, malignancy	Urgent MRI, CSF analysis, autoantibody panel, consider prion markers
Fluctuating cognition + visual hallucinations	Lewy body dementia	Avoid antipsychotics; consider DaTscan if uncertain
Personality change before memory loss	Frontotemporal dementia	MRI for frontal/temporal atrophy; consider genetic testing if familial
Gait disturbance + incontinence + dementia	Normal pressure hydrocephalus	MRI; large-volume lumbar puncture trial
Stepwise decline + vascular risk factors	Vascular dementia	MRI for infarcts/white matter disease; vascular risk factor management
Memory complaints + preserved daily function	Mild cognitive impairment or subjective cognitive decline	Formal neuropsychological testing; monitor for progression
Alcohol history + confabulation	Korsakoff syndrome	Give thiamine; MRI for mammillary body changes
New seizures + psychiatric symptoms + young patient	Autoimmune encephalitis	CSF and serum autoantibodies; MRI; consider empiric immunotherapy
Sudden onset + resolves within 24 hours	Transient global amnesia	MRI (may show hippocampal DWI changes); reassurance; low recurrence risk
Mood symptoms + “I don’t know” responses	Depression (pseudodementia)	Depression screening; trial of antidepressant therapy
Multiple medications with anticholinergic properties	Medication-induced cognitive impairment	Calculate Anticholinergic Burden Score; deprescribe where possible

6. Diagnostic Investigations

A stepwise, cost-effective approach guided by clinical suspicion

Baseline Investigations for All Patients

The following investigations should be performed in all patients presenting with memory impairment to screen for reversible causes:

Investigation	Purpose	What to Look For	Practical Points
Complete blood count	Screen for anemia, infection, hematologic malignancy	Macrocytic anemia (B12/folate); infection markers	MCV greater than 100 fL should prompt B12/folate testing
Comprehensive metabolic panel	Electrolytes, renal function, liver function, glucose	Hyponatremia, hypercalcemia, uremia, hepatic dysfunction, hypoglycemia	Hyponatremia common in elderly and with SIADH (including from anti-LGI1 encephalitis)
Thyroid-stimulating hormone (TSH)	Screen for thyroid dysfunction	Elevated TSH (hypothyroidism) or suppressed TSH (hyperthyroidism)	Hypothyroidism is treatable cause; check free T4 if TSH abnormal
Vitamin B12 level	Screen for deficiency	Level less than 200 pg/mL is deficient; 200-400 pg/mL is borderline	If borderline, check methylmalonic acid (elevated in true deficiency)
Folate level	Screen for deficiency	Low folate (less than 3 ng/mL)	Less common cause than B12; often coexists with B12 deficiency
MRI brain	Assess for structural lesions, atrophy pattern, vascular disease	Atrophy pattern; white matter disease; masses; hydrocephalus; infarcts	Include coronal T1 for hippocampal assessment; FLAIR for white matter

Additional Tests to Consider in All Patients

Investigation	When to Order	What to Look For
Syphilis serology (RPR or VDRL)	All patients with dementia; particularly if risk factors or atypical presentation	Positive serology requires confirmatory testing and CSF examination
HIV testing	All patients unless already known; especially if risk factors or younger onset	HIV-associated neurocognitive disorder is treatable with antiretroviral therapy
Erythrocyte sedimentation rate (ESR) / C-reactive protein (CRP)	If inflammatory, infectious, or autoimmune cause suspected	Elevated inflammatory markers suggest infection, vasculitis, or autoimmune process
Urinalysis	Elderly patients; suspected delirium	Urinary tract infection is common precipitant of delirium in elderly
ECG	All patients with vascular risk factors or suspected vascular dementia	Atrial fibrillation (embolic stroke risk); prior infarction

Targeted Investigations by Suspected Etiology

If Suspecting Alzheimer’s Disease

First-Line Tests

MRI brain: Medial temporal lobe atrophy (especially hippocampus); parietal atrophy; Scheltens scale can quantify hippocampal atrophy (grade 0-4)
Neuropsychological testing: Confirms pattern of deficits; establishes baseline for monitoring

Second-Line / Specialized Tests

CSF biomarkers: Decreased amyloid-beta 42, increased total tau and phospho-tau (181); high sensitivity and specificity
Amyloid PET imaging: Detects amyloid deposition; negative scan makes Alzheimer’s unlikely
FDG-PET: Temporoparietal hypometabolism pattern

If Suspecting Vascular Dementia

First-Line Tests

MRI brain: Multiple infarcts, strategic single infarcts, or extensive white matter hyperintensities (Fazekas scale grade 2-3)
Vascular risk factor assessment: HbA1c, lipid panel, blood pressure monitoring

Second-Line Tests

Carotid ultrasound / CT angiography: Assess for significant carotid stenosis
Echocardiography: If cardioembolic source suspected
24-hour Holter monitor: Screen for paroxysmal atrial fibrillation

If Suspecting Lewy Body Dementia

First-Line Tests

MRI brain: Relative preservation of medial temporal lobes compared to Alzheimer’s
Clinical assessment: Core features (fluctuations, visual hallucinations, parkinsonism, REM sleep behavior disorder)

Supportive Investigations

DaTscan (dopamine transporter SPECT): Reduced uptake in basal ganglia supports diagnosis
Polysomnography: Confirms REM sleep behavior disorder
MIBG cardiac scintigraphy: Reduced uptake indicates cardiac sympathetic denervation

If Suspecting Frontotemporal Dementia

First-Line Tests

MRI brain: Frontal and/or anterior temporal atrophy (often asymmetric); “knife-edge” gyri in advanced cases
Neuropsychological testing: Executive dysfunction; language deficits in language variants

Second-Line Tests

FDG-PET: Frontal and/or temporal hypometabolism
Genetic testing: Consider if strong family history (C9orf72, MAPT, GRN mutations)
EMG: If motor neuron disease features present (FTD-ALS spectrum)

If Suspecting Normal Pressure Hydrocephalus

First-Line Tests

MRI brain: Ventriculomegaly out of proportion to sulcal enlargement; Evans index greater than 0.3; callosal angle less than 90 degrees; DESH (disproportionately enlarged subarachnoid-space hydrocephalus) pattern

Diagnostic/Therapeutic Trial

Large-volume lumbar puncture: Remove 30-50 mL CSF; assess gait before and 1-4 hours after
Extended lumbar drainage: 3-5 days of continuous drainage if LP equivocal
CSF infusion study: Measures resistance to CSF outflow

If Suspecting Autoimmune Encephalitis

First-Line Tests

MRI brain: Medial temporal lobe T2/FLAIR hyperintensity; may be normal
CSF analysis: Lymphocytic pleocytosis; elevated protein; oligoclonal bands
Serum and CSF autoantibody panel: Anti-LGI1, anti-CASPR2, anti-NMDAR, anti-GABA-B, anti-AMPA, anti-Hu, anti-Ma2

Additional Workup

EEG: May show focal or generalized slowing; extreme delta brush in anti-NMDAR
CT chest/abdomen/pelvis: Screen for occult malignancy (paraneoplastic)
Pelvic ultrasound: Ovarian teratoma in anti-NMDAR encephalitis
PET-CT: If paraneoplastic suspected and CT negative

If Suspecting Rapidly Progressive Dementia / Prion Disease

First-Line Tests

MRI brain with DWI: Cortical ribboning; basal ganglia hyperintensity on DWI/FLAIR; “hockey stick” sign in pulvinar
CSF analysis: 14-3-3 protein (sensitivity approximately 90%); neuron-specific enolase; RT-QuIC (highly specific)
EEG: Periodic sharp wave complexes (seen in approximately 60%)

Additional Workup

Comprehensive autoimmune panel: Must exclude treatable autoimmune encephalitis
Genetic testing: PRNP gene for familial prion disease
Brain biopsy: Rarely needed; consider if diagnosis uncertain and treatable cause possible

Empiric Treatment Trials as Diagnostic Tools

Treatment Trials in Memory Impairment

In certain clinical scenarios, empiric treatment can serve as both a diagnostic and therapeutic intervention. Response to treatment supports the diagnosis.

Thiamine replacement: Give IV thiamine (500 mg three times daily for 3 days, then 250 mg daily) in any patient with suspected Wernicke encephalopathy—do not wait for thiamine levels. Response supports diagnosis.
Antidepressant trial: If depression is suspected contributor (“pseudodementia”), a 6-8 week trial of antidepressant therapy may improve cognition significantly.
Large-volume lumbar puncture: In suspected normal pressure hydrocephalus, improvement in gait and cognition after removing 30-50 mL CSF supports the diagnosis and predicts shunt response.
Medication discontinuation: If drug-induced cognitive impairment suspected, discontinue or reduce offending medications and reassess after appropriate washout period.
Immunotherapy trial: In suspected autoimmune encephalitis with high clinical suspicion, empiric immunotherapy (corticosteroids, IVIG) may be initiated while awaiting antibody results.

MRI Patterns in Memory Impairment

Condition	Characteristic MRI Finding	Key Sequences
Alzheimer’s disease	Medial temporal lobe atrophy (hippocampus, entorhinal cortex); parietal atrophy	Coronal T1 for hippocampal volume
Vascular dementia	Multiple infarcts; extensive white matter hyperintensities; lacunes in basal ganglia/thalamus	FLAIR; T2; DWI for acute infarcts
Lewy body dementia	Relative preservation of medial temporal lobes; posterior atrophy may be present	T1 volumetric
Frontotemporal dementia	Frontal and/or anterior temporal atrophy (often asymmetric)	T1 volumetric; coronal views
Normal pressure hydrocephalus	Ventriculomegaly; Evans index greater than 0.3; tight high-convexity sulci; callosal angle less than 90 degrees	T1; FLAIR; cine MRI for CSF flow
Creutzfeldt-Jakob disease	Cortical ribboning; basal ganglia hyperintensity; pulvinar sign (variant CJD)	DWI (most sensitive); FLAIR
Autoimmune encephalitis	Medial temporal lobe T2/FLAIR hyperintensity (often bilateral); may be normal	FLAIR; T2
Herpes simplex encephalitis	Asymmetric temporal lobe edema and hyperintensity; may involve insular cortex	FLAIR; DWI; T2
Wernicke encephalopathy	Mammillary body and periaqueductal gray enhancement/hyperintensity; medial thalami	FLAIR; T1 with contrast

CSF Biomarkers in Dementia

Biomarker	Alzheimer’s Disease Pattern	Other Considerations
Amyloid-beta 42 (Aβ42)	Decreased (less than 500 pg/mL typically)	Reflects amyloid deposition in brain; also decreased in Lewy body dementia
Total tau (t-tau)	Increased (greater than 400 pg/mL typically)	Non-specific marker of neurodegeneration; very high in CJD
Phospho-tau 181 (p-tau)	Increased (greater than 60 pg/mL typically)	More specific for Alzheimer’s pathology than t-tau
Aβ42/Aβ40 ratio	Decreased (less than 0.05-0.1 depending on assay)	More reliable than Aβ42 alone; accounts for individual variation
Neurofilament light chain (NfL)	Mildly elevated	Non-specific neurodegeneration marker; very high in FTD, CJD, ALS

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Rapid progression over days to weeks; fever; seizures; movement disorder	EMERGENT	Admit; MRI brain urgently; lumbar puncture; consider empiric acyclovir and immunotherapy; autoantibody panel
Acute confusion with fluctuating consciousness; new focal signs	EMERGENT	Evaluate for delirium causes; CT/MRI brain; metabolic workup; consider stroke protocol if focal
Sudden-onset amnesia lasting less than 24 hours; repetitive questioning	URGENT	Evaluate for transient global amnesia vs. seizure vs. stroke; MRI with DWI; observation
Progressive decline over weeks to months; myoclonus; ataxia	URGENT	MRI with DWI; CSF analysis including 14-3-3 and RT-QuIC; EEG; exclude treatable mimics
Gait disturbance with incontinence and cognitive decline	URGENT	MRI brain; if hydrocephalus present, refer neurosurgery for LP trial; potentially reversible
Gradual memory decline over months to years; no red flags	ROUTINE	Outpatient evaluation; baseline labs; MRI brain; neuropsychological testing; reversible causes screen
Subjective memory complaints; normal daily functioning	ROUTINE	Screen for depression/anxiety; cognitive screening; reassurance if normal; monitor for progression

Step 2: Classify by Onset and Tempo

Acute (Minutes to Hours)

Key considerations:

Transient global amnesia
Seizure (transient epileptic amnesia)
Stroke
Delirium
Hypoglycemia

Proceed to Algorithm A

Subacute (Days to Weeks)

Key considerations:

Autoimmune encephalitis
Infectious encephalitis
Wernicke encephalopathy
Prion disease
Malignancy

Proceed to Algorithm B

Chronic (Months to Years)

Key considerations:

Alzheimer’s disease
Vascular dementia
Lewy body dementia
Frontotemporal dementia
Reversible causes

Proceed to Algorithm C

Step 3: Follow the Appropriate Algorithm

Algorithm A: Acute Memory Impairment

Clinical Scenario	Most Likely Diagnosis	Action
Sudden-onset dense amnesia; repetitive questioning; lasts less than 24 hours; resolves completely; no focal signs	Transient global amnesia	MRI with DWI (may show hippocampal lesions); reassure; low recurrence risk; no specific treatment needed
Brief amnestic episodes (less than 1 hour); often on waking; recurrent; may have subtle automatisms	Transient epileptic amnesia	EEG (may need sleep-deprived or prolonged); MRI; antiepileptic therapy if confirmed
Sudden onset with focal neurological signs; vascular risk factors; atrial fibrillation	Stroke (hippocampal, thalamic, or PCA territory)	Stroke protocol; CT/MRI; vascular imaging; secondary prevention
Fluctuating attention and awareness; identifiable precipitant; acute onset	Delirium	Identify and treat underlying cause; medication review; supportive care
Confusion in diabetic patient on insulin or sulfonylurea; sweating; tremor	Hypoglycemia	Check glucose immediately; treat with glucose; adjust diabetic regimen

Algorithm B: Subacute Memory Impairment

Critical Principle

Subacute onset demands urgent evaluation. Many causes are treatable if caught early but cause irreversible damage if delayed. Always consider autoimmune encephalitis and infections—treat empirically while awaiting results if clinical suspicion is high.

Clinical Scenario	Most Likely Diagnosis	Action
Subacute amnesia; seizures; hyponatremia; faciobrachial dystonic seizures; older adult	Anti-LGI1 encephalitis	Serum and CSF autoantibodies; MRI; start immunotherapy early (steroids, IVIG)
Young woman; psychiatric symptoms; seizures; movement disorder; autonomic instability	Anti-NMDA receptor encephalitis	CSF antibodies; pelvic imaging for ovarian teratoma; immunotherapy; tumor removal if present
Fever; headache; behavioral change; temporal lobe abnormality on MRI	Herpes simplex encephalitis	Start IV acyclovir immediately; CSF HSV PCR; do not wait for results to treat
Alcohol or malnutrition history; ophthalmoplegia; ataxia; confusion	Wernicke encephalopathy	IV thiamine 500 mg three times daily immediately; do not give glucose before thiamine
Rapid cognitive decline; myoclonus; ataxia; cortical ribboning on MRI DWI	Creutzfeldt-Jakob disease	MRI with DWI; CSF 14-3-3 and RT-QuIC; EEG; exclude treatable mimics; supportive care
Progressive cognitive decline; weight loss; history of malignancy or smoking	Paraneoplastic or metastatic disease	Paraneoplastic antibody panel; CT chest/abdomen/pelvis; PET-CT; MRI with contrast

Algorithm C: Chronic Memory Impairment

Clinical Scenario	Most Likely Diagnosis	Action
Gradual onset; episodic memory impairment; word-finding difficulty; preserved personality early	Alzheimer’s disease	MRI (hippocampal atrophy); consider CSF biomarkers or amyloid PET if uncertain; cholinesterase inhibitor
Stepwise decline; vascular risk factors; executive dysfunction; white matter changes on MRI	Vascular dementia	MRI; vascular risk factor modification; antiplatelet therapy; consider cholinesterase inhibitor
Fluctuating cognition; visual hallucinations; parkinsonism; REM sleep behavior disorder	Lewy body dementia	Clinical diagnosis; DaTscan if uncertain; avoid antipsychotics; cholinesterase inhibitor (often good response)
Personality change; disinhibition or apathy; relatively preserved memory early; age under 65	Frontotemporal dementia (behavioral variant)	MRI (frontal/temporal atrophy); genetic testing if familial; symptomatic management; no disease-modifying therapy
Gait disturbance first; then incontinence; then dementia; ventricular enlargement	Normal pressure hydrocephalus	MRI; large-volume LP trial; if improved, refer for shunt surgery
Mood symptoms prominent; “I don’t know” responses; improves with cues; subjective worse than objective	Depression (pseudodementia)	Depression screening; antidepressant trial; cognitive reassessment after treatment
Multiple medications with anticholinergic properties; cognitive decline correlates with medication changes	Medication-induced cognitive impairment	Medication review; calculate Anticholinergic Burden Score; deprescribe; reassess in 4-8 weeks

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
MRI shows medial temporal lobe hyperintensity	Consider autoimmune or infectious encephalitis	CSF analysis; autoantibody panel; consider empiric acyclovir and immunotherapy
CSF shows lymphocytic pleocytosis	Infectious or autoimmune process likely	HSV PCR; autoantibodies; consider TB, fungal, and other infectious causes
Patient improves dramatically after lumbar puncture	Strongly supports normal pressure hydrocephalus	Document gait improvement; refer neurosurgery for shunt evaluation
Family reports patient sees people who aren’t there	Consider Lewy body dementia	Assess for other core features; avoid antipsychotics; consider DaTscan
Cognitive testing shows isolated memory impairment with preserved daily function	Mild cognitive impairment (amnestic type)	Baseline biomarkers if desired; lifestyle modification; monitor every 6-12 months
Patient has prominent behavioral changes before memory loss	Consider frontotemporal dementia	MRI for frontal/temporal atrophy; neuropsychological testing; genetic counseling if familial
All investigations normal but symptoms persist	Reassess for depression, anxiety, sleep disorder, or early neurodegenerative disease	Formal neuropsychological testing; longitudinal follow-up; repeat imaging in 1-2 years if progressive
Patient is on multiple anticholinergic medications	Calculate Anticholinergic Burden Score	Systematic deprescribing; substitute with less anticholinergic alternatives; reassess cognition after washout
Rapidly progressive dementia with negative autoimmune workup	Consider prion disease, but repeat autoimmune testing	MRI with DWI; CSF RT-QuIC; EEG; some autoantibodies may be negative initially—consider empiric immunotherapy trial
Young patient (under 65) with progressive dementia	Early-onset dementia requires thorough evaluation	Complete reversible causes screen; genetic testing consideration; specialized memory clinic referral

Troubleshooting: Refractory or Unclear Cases

Ask These Questions When Diagnosis Is Uncertain

Have all reversible causes been excluded? Recheck B12, thyroid, medications, depression
Was collateral history obtained? Family members may reveal key details patient cannot provide
Is the cognitive profile consistent with the suspected diagnosis? Atypical patterns warrant reconsideration
Has sufficient time passed? Some diagnoses require longitudinal observation
Are there multiple overlapping causes? Mixed pathology is common, especially in elderly
Should advanced biomarkers be obtained? CSF or amyloid PET may clarify uncertain cases
Is specialized referral needed? Memory clinic, behavioral neurology, or neuropsychology
Should empiric treatment be tried? Antidepressant trial, LP trial for NPH, medication discontinuation

When to Refer to Specialist

Indication	Specialist	Reason
Early-onset dementia (under age 65)	Memory clinic / Behavioral neurologist	Higher likelihood of atypical or genetic causes; specialized testing needed
Rapidly progressive dementia	Neurologist (urgent)	Exclude treatable causes; prion disease workup
Suspected autoimmune encephalitis	Neurologist (urgent)	Early immunotherapy improves outcomes
Suspected normal pressure hydrocephalus	Neurosurgery	LP trial and shunt evaluation
Atypical presentation or diagnostic uncertainty	Neuropsychologist / Memory clinic	Formal cognitive profiling; longitudinal monitoring
Significant behavioral or psychiatric symptoms	Geriatric psychiatry / Behavioral neurology	Management of neuropsychiatric symptoms; medication optimization
Strong family history of dementia	Genetic counselor / Specialized clinic	Genetic testing considerations; family counseling

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

Collateral history is essential: Memory-impaired patients often lack insight or cannot provide accurate history. Always interview a family member or caregiver separately—discrepancies between patient and informant accounts are diagnostically valuable.

Retrieval versus encoding: Patients who improve with cues have retrieval deficits (frontal dysfunction, depression, subcortical disease). Those who do not improve have encoding deficits (hippocampal pathology, Alzheimer’s disease). This distinction guides diagnosis.

The triad of normal pressure hydrocephalus appears in order: Gait disturbance typically comes first, then urinary symptoms, then dementia. If memory loss preceded gait problems by years, NPH is less likely.

Lewy body dementia patients are exquisitely sensitive to antipsychotics: Even small doses can cause severe parkinsonism, rigidity, and neuroleptic malignant syndrome. If you must treat psychosis, use low-dose quetiapine or consider pimavanserin.

Give thiamine before glucose: In any patient with possible Wernicke encephalopathy, give IV thiamine before glucose administration. Glucose metabolism consumes thiamine and can precipitate acute Wernicke’s in deficient patients.

The Wernicke triad is usually incomplete: The classic triad of ophthalmoplegia, ataxia, and confusion is present in only 10-15% of cases. Maintain high suspicion in any at-risk patient (alcohol use disorder, malnutrition, bariatric surgery, hyperemesis).

Anti-LGI1 encephalitis has a unique seizure type: Faciobrachial dystonic seizures (brief, frequent arm and face jerking) are highly specific for anti-LGI1 encephalitis and often precede cognitive decline. Recognizing this pattern enables early treatment.

DWI is the most sensitive MRI sequence for prion disease: Cortical ribboning and basal ganglia hyperintensity on diffusion-weighted imaging are often visible before FLAIR changes. Always request DWI when prion disease is suspected.

Critical Pitfalls to Avoid

Assuming all memory complaints in elderly are “just aging”: While some cognitive slowing is normal, significant memory impairment always warrants evaluation. Up to 20% of patients have potentially reversible causes.

Diagnosing dementia without excluding delirium: Delirium can present with memory impairment and is often superimposed on dementia. Always assess attention and look for fluctuation before diagnosing or progressing dementia.

Missing autoimmune encephalitis: Subacute cognitive decline with seizures, psychiatric symptoms, or movement disorders should trigger autoantibody testing. Early immunotherapy dramatically improves outcomes—don’t wait for antibody results if clinical suspicion is high.

Overlooking medication-induced cognitive impairment: Anticholinergic burden is cumulative. Review all medications including over-the-counter drugs. The Anticholinergic Burden Score helps quantify risk.

Prescribing antipsychotics to patients with Lewy body dementia: Severe neuroleptic sensitivity can cause catastrophic worsening. Always consider Lewy body dementia before prescribing antipsychotics to any patient with dementia and visual hallucinations or parkinsonism.

Dismissing depression as a cause of cognitive symptoms: “Pseudodementia” from depression can cause severe objective impairment. A treatment trial may be diagnostic and therapeutic—significant improvement supports the diagnosis.

Stopping evaluation after finding one abnormality: Mixed pathology is common, especially in elderly patients. Finding vascular changes doesn’t exclude concurrent Alzheimer’s disease; finding hippocampal atrophy doesn’t exclude a medication effect.

Relying solely on patient-reported history: Patients with anosognosia (lack of insight) may minimize or deny symptoms. Patients with depression may exaggerate them. Collateral history is essential for accurate assessment.

Key Takeaways

Memory impairment is a symptom, not a diagnosis—always seek the underlying cause through systematic evaluation.
Tempo of onset is the most important initial classifier: acute, subacute, and chronic presentations have different differentials and urgencies.
Up to 20% of dementia presentations have potentially reversible causes—always screen for depression, medications, B12, thyroid, and structural lesions.
Collateral history from family or caregivers is essential and often more reliable than patient self-report.
The pattern of cognitive deficits (which domains affected, response to cueing) helps localize pathology and narrow the differential.
Subacute onset demands urgent evaluation—autoimmune encephalitis and infections are treatable but time-sensitive.
Normal pressure hydrocephalus is one of the few surgically treatable causes of dementia—recognize the triad and the characteristic gait.
Avoid antipsychotics in suspected Lewy body dementia—the consequences of neuroleptic sensitivity can be severe.
A normal neurological examination does not exclude significant pathology—many dementias have normal examinations early in the course.
Consider empiric treatment trials (thiamine, antidepressants, LP trial, medication discontinuation) when appropriate—they can be both diagnostic and therapeutic.

Quick Reference Algorithm

Systematic Approach to Memory Impairment:

Assess urgency: Is this acute/subacute (urgent) or chronic (routine)? Look for red flags.
Obtain collateral history: Interview family member separately; assess onset, progression, functional impact.
Perform cognitive and neurological examination: Characterize the cognitive profile; look for associated neurological signs.
Screen for reversible causes: Labs (B12, TSH, metabolic panel), medication review, depression screening.
Obtain neuroimaging: MRI brain with attention to atrophy pattern, vascular disease, and structural lesions.
Consider targeted investigations: Based on clinical suspicion (CSF analysis, autoantibodies, advanced biomarkers, LP trial).
Formulate diagnosis: Integrate history, examination, and investigations; consider mixed pathology.
Develop management plan: Address reversible factors, initiate appropriate therapy, plan follow-up, support caregivers.